欧洲对乳腺癌预测性检测独家控制权的反对以及对美国专利法和公共政策的内在影响：以Myriad Genetics公司的BRCA专利争议为例 - Suppr

European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.

作者信息

Paradise Jordan

机构信息

Institute for Science, Law and Technology, Chicago-Kent College of Law, Illinois Institute of Technology, Chicago, Ill., USA.

出版信息

Food Drug Law J. 2004;59(1):133-54.

PMID:15190928

Abstract

摘要

相似文献

European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.

Food Drug Law J. 2004;59(1):133-54.

Patents. U.S. appeals court hears gene patent arguments.

Science. 2012 Jul 20;337(6092):277-8. doi: 10.1126/science.337.6092.277.

Ruling on BRCA gene patents could have limited impact.

J Natl Cancer Inst. 2010 Jun 2;102(11):754-7. doi: 10.1093/jnci/djq209. Epub 2010 May 24.

History of a gene patent: tracing the development and application of commercial BRCA testing.

Health Law J. 2002;10:123-46.

Direct to confusion: lessons learned from marketing BRCA testing.

Am J Bioeth. 2008 Jun;8(6):5-8. doi: 10.1080/15265160802248179.

[Federal judge and government of the United States against gene patenting].

Med Sci (Paris). 2011 Jun-Jul;27(6-7):662-6. doi: 10.1051/medsci/2011276020. Epub 2011 Jul 1.

[Opposition to Myriad Genetics patents and their total or partial revocation in Europe: early conclusions].

Med Sci (Paris). 2005 Jun-Jul;21(6-7):658-62. doi: 10.1051/medsci/2005216-7658.

French researchers take a stand against cancer gene patent.

Nature. 2001 Sep 13;413(6852):95-6. doi: 10.1038/35093217.

Cancer research. Transatlantic war over BRCA1 patent.

Science. 2001 Jun 8;292(5523):1818. doi: 10.1126/science.292.5523.1818.

US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes.

BMJ. 2012 Oct 2;345:e6624. doi: 10.1136/bmj.e6624.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.

作者信息

Paradise Jordan

机构信息

Institute for Science, Law and Technology, Chicago-Kent College of Law, Illinois Institute of Technology, Chicago, Ill., USA.

出版信息

Food Drug Law J. 2004;59(1):133-54.

PMID:15190928

Abstract

摘要

相似文献

Food Drug Law J. 2004;59(1):133-54.

Patents. U.S. appeals court hears gene patent arguments.

Science. 2012 Jul 20;337(6092):277-8. doi: 10.1126/science.337.6092.277.

Ruling on BRCA gene patents could have limited impact.

J Natl Cancer Inst. 2010 Jun 2;102(11):754-7. doi: 10.1093/jnci/djq209. Epub 2010 May 24.

History of a gene patent: tracing the development and application of commercial BRCA testing.

Health Law J. 2002;10:123-46.

Direct to confusion: lessons learned from marketing BRCA testing.

Am J Bioeth. 2008 Jun;8(6):5-8. doi: 10.1080/15265160802248179.

[Federal judge and government of the United States against gene patenting].

Med Sci (Paris). 2011 Jun-Jul;27(6-7):662-6. doi: 10.1051/medsci/2011276020. Epub 2011 Jul 1.

[Opposition to Myriad Genetics patents and their total or partial revocation in Europe: early conclusions].

Med Sci (Paris). 2005 Jun-Jul;21(6-7):658-62. doi: 10.1051/medsci/2005216-7658.

French researchers take a stand against cancer gene patent.

Nature. 2001 Sep 13;413(6852):95-6. doi: 10.1038/35093217.

Cancer research. Transatlantic war over BRCA1 patent.

Science. 2001 Jun 8;292(5523):1818. doi: 10.1126/science.292.5523.1818.

US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes.

BMJ. 2012 Oct 2;345:e6624. doi: 10.1136/bmj.e6624.

European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.

作者信息

机构信息

出版信息

相似文献